slides · global inventory
Problem Agitate Solution Problem Identify Pain
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 3,748
Current window 2,821-2,850
Pages 125
Rows per page 30
Beat
2,821-2,850 of 3,748
03
Uses a comparison to the scale of the universe to frame the problem as an intractable search space.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · Problem1 hit
04
Uses a simple visual metaphor of a subset circle to illustrate the problem of low success rates in drug discovery.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · Problem1 hit
05
Uses a Venn-style diagram to illustrate the small overlap between screening and successful drug candidates.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · Problem1 hit
07
The slide uses a hierarchical diagram to map the clinical manifestations of the disease.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
08
The diagram illustrates the metabolic pathway and the specific block at the Cystathionine beta-synthase step.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
09
The table contrasts clinical outcomes (Hcy levels, lens dislocation, IQ, thrombosis, mortality) between two patient cohorts.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
10
Includes a citation of the specific clinical guidelines paper.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
06
Includes a photo of a child with medical equipment to humanize the disease impact.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · Problem1 hit
05
Aldeyra Therapeutics | Results Presentation Deck | 13 slidesAldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
14
The slide uses a before-after-bridge style logic to explain why international operations are underperforming.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations Beat · Problem1 hit
05
Uses a two-column layout to contrast 'Significant Burden' with 'Urgent Need for Innovation'.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
01
Includes company logo, date, and corporate tagline.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
Uses a before-after-bridge style structure to contrast vaccine efficacy with remaining clinical challenges.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide displays two forest plots showing confidence intervals for vaccine effectiveness across multiple studies.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
01
BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slidesBrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Problem1 hit
02
The chart is a dot plot comparing baseline ALSFRS-R scores across various clinical trials, highlighting NurOwn's lower baseline.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
The slide highlights a subgroup analysis where the treatment effect becomes statistically significant (p=0.050) in the secondary endpoint.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Before After1 hit
11
The slide uses a dual-pillar structure to present sustainability goals and quantitative targets for 2025, 2030, and 2050.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
12
Braskem | ESG Presentation Deck | 54 slidesBraskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
13
The slide uses a numbered list structure to define the three work fronts.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
14
The slide uses a numbered list format to define the three work fronts.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
15
The slide uses a structured pillar-based framework to categorize the company's decarbonization strategy.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
07
Credit Suisse | Investor Event Presentation Deck | 43 slidesCredit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
01
Includes company logo, presenter names, date, and corporate tagline.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · Problem1 hit
02
Immatics | Results Presentation Deck | 25 slidesImmatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · Problem1 hit
03
Includes histological images of PRAME expression and a table of prevalence by indication.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · Problem1 hit
04
The slide uses a process flow diagram to show the progression of clinical trial cohorts.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · Problem1 hit
05
The slide uses a process flow diagram to illustrate trial cohorts. Cohorts B and C are greyed out, indicating they are not the focus of this specific update.Immatics | Results Presentation Deck | 25 slides · Immatics
Conference presentation Investor relations Beat · Problem1 hit
04
Includes a list of abbreviations at the bottom.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit